Takeda and HUTCHMED Limited today announced that the U.S. Food and Drug Administration has granted priority review of the New Drug Application (NDA) for fruquintinib, a highly selective

FivepHusion, an advanced clinical-stage biotechnology company, today announced its collaboration with Treehill Partners, a New York-based strategic and financial advisory firm

Synapse Medicine, the leader in medication success, and CompuGroup Medical, the leader in software for providers, have announced a partnership to accelerate innovation in prescribing

IQVIA? a leading global provider of advanced analytics, technology solutions, and clinical research services to the life science industry, announced a groundbreaking partnership today

Celltrion USA today announced that the U.S. Food and Drug Administration has approved Yuflyma, a high-concentration and citrate-free formulation of Humira? (adalimumab) biosimilar.

Today, the U.S. Food and Drug Administration approved Xacduro , a new treatment for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused

Tampa General Hospital one of the nation?s top 10 transplant centers, wrote a new chapter in its history earlier this month with its first living donor liver transplant, which also is the first such surgery on Florida?s west coast.

BPGbio, Inc., a leading AI-powered biopharma that focuses on oncology, neurology and rare diseases, today announced that it will continue clinical validation of a novel breast cancer

Linkwell Health, the premier consumer engagement technology company in healthcare, and Avesis, one of the nation?s leading providers of dental, vision, and specialty benefits, announced

Amulet Capital Partners, LP, a middle-market private equity investment firm focused exclusively on the healthcare sector, today announced it has acquired Alliance Clinical Network